Operating Income - Nanobiotix SA (PAR:NANO) - Alpha Spread

Nanobiotix SA
PAR:NANO

Watchlist Manager
Nanobiotix SA Logo
Nanobiotix SA
PAR:NANO
Watchlist
Price: 4.646 EUR 4.31% Market Closed
Market Cap: 220.2m EUR
Have any thoughts about
Nanobiotix SA?
Write Note

Nanobiotix SA
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Nanobiotix SA
Operating Income Peer Comparison

Comparables:
VLA
IPH
GNFT
ALERS
OSE

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Nanobiotix SA
PAR:NANO
Operating Income
-€26.8m
CAGR 3-Years
10%
CAGR 5-Years
2%
CAGR 10-Years
-13%
Valneva SE
PAR:VLA
Operating Income
-€136.2m
CAGR 3-Years
-5%
CAGR 5-Years
N/A
CAGR 10-Years
-19%
Innate Pharma SA
PAR:IPH
Operating Income
-€38.6m
CAGR 3-Years
-58%
CAGR 5-Years
N/A
CAGR 10-Years
-15%
Genfit SA
NASDAQ:GNFT
Operating Income
-€26.7m
CAGR 3-Years
30%
CAGR 5-Years
17%
CAGR 10-Years
-10%
Eurobio Scientific SA
PAR:ALERS
Operating Income
€14.5m
CAGR 3-Years
-44%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
OSE Immunotherapeutics SA
PAR:OSE
Operating Income
-€23.3m
CAGR 3-Years
-7%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Nanobiotix SA's Operating Income?
Operating Income
-26.8m EUR

Based on the financial report for Dec 31, 2023, Nanobiotix SA's Operating Income amounts to -26.8m EUR.

What is Nanobiotix SA's Operating Income growth rate?
Operating Income CAGR 10Y
-13%

Over the last year, the Operating Income growth was 43%. The average annual Operating Income growth rates for Nanobiotix SA have been 10% over the past three years , 2% over the past five years , and -13% over the past ten years .

Back to Top